Abliva
1 known investors
Find your way into Abliva
Abliva develops treatments for primary mitochondrial disease, a rare orphan disease caused by impaired cellular energy metabolism in the mitochondria. The company focuses on pharmaceutical research and development to address an unmet medical need where no effective treatments currently exist.
Investors · 1
In the news
Frequently asked questions
- What does Abliva do?
- Abliva develops treatments for primary mitochondrial disease, a rare orphan disease caused by impaired cellular energy metabolism in the mitochondria. The company focuses on pharmaceutical research and development to address an unmet medical need where no effective treatments currently exist.
- Who are Abliva's investors?
- Abliva's investors include Hadean Ventures.